Delray Beach Weight Loss Clinic
US$ 27.88
do not combine dpp-4 inhibitors with glp-1 receptor agonists guidance Comparison of and Dipeptidyl Peptidase 4 Inhibitors: Novel
Description
The difference is FDA approval: Mounjaro is approved for type 2 diabetes, and Zepbound is approved for chronic weight management
Tirzepatide is the active ingredient in Zepbound, a GLP-1 receptor agonist
Cell, 153(6), 11941217
Lehto, S
Eur J Biochem 214:829835 Seino Y, Fukushima M, Yabe D (2010) GIP and GLP-1, the two incretin hormones: similarities and differences
